U S Department of Health and Human Services www.hhs.gov
Centers for Medicare & Medicaid Services
ICD-10-CM/PCS MS-DRGv33 Definitions Manual Previous Page [Alt-p] Up a level [Alt-u] Next Page [Alt-n]
MDC 21 Assignment of Diagnosis Codes
Page 9 of 15
T44904APoisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, initial encounter
T44904SPoisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, sequela
T44905AAdverse effect of unspecified drugs primarily affecting the autonomic nervous system, initial encounter
T44905SAdverse effect of unspecified drugs primarily affecting the autonomic nervous system, sequela
T44991APoisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), initial encounter
T44991SPoisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), sequela
T44992APoisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, initial encounter
T44992SPoisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, sequela
T44993APoisoning by other drug primarily affecting the autonomic nervous system, assault, initial encounter
T44993SPoisoning by other drug primarily affecting the autonomic nervous system, assault, sequela
T44994APoisoning by other drug primarily affecting the autonomic nervous system, undetermined, initial encounter
T44994SPoisoning by other drug primarily affecting the autonomic nervous system, undetermined, sequela
T44995AAdverse effect of other drug primarily affecting the autonomic nervous system, initial encounter
T44995SAdverse effect of other drug primarily affecting the autonomic nervous system, sequela
T450X1APoisoning by antiallergic and antiemetic drugs, accidental (unintentional), initial encounter
T450X1SPoisoning by antiallergic and antiemetic drugs, accidental (unintentional), sequela
T450X2APoisoning by antiallergic and antiemetic drugs, intentional self-harm, initial encounter
T450X2SPoisoning by antiallergic and antiemetic drugs, intentional self-harm, sequela
T450X3APoisoning by antiallergic and antiemetic drugs, assault, initial encounter
T450X3SPoisoning by antiallergic and antiemetic drugs, assault, sequela
T450X4APoisoning by antiallergic and antiemetic drugs, undetermined, initial encounter
T450X4SPoisoning by antiallergic and antiemetic drugs, undetermined, sequela
T450X5AAdverse effect of antiallergic and antiemetic drugs, initial encounter
T450X5SAdverse effect of antiallergic and antiemetic drugs, sequela
T451X1APoisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encounter
T451X1SPoisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), sequela
T451X2APoisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, initial encounter
T451X2SPoisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, sequela
T451X3APoisoning by antineoplastic and immunosuppressive drugs, assault, initial encounter
T451X3SPoisoning by antineoplastic and immunosuppressive drugs, assault, sequela
T451X4APoisoning by antineoplastic and immunosuppressive drugs, undetermined, initial encounter
T451X4SPoisoning by antineoplastic and immunosuppressive drugs, undetermined, sequela
T451X5AAdverse effect of antineoplastic and immunosuppressive drugs, initial encounter
T451X5SAdverse effect of antineoplastic and immunosuppressive drugs, sequela
T452X1APoisoning by vitamins, accidental (unintentional), initial encounter
T452X1SPoisoning by vitamins, accidental (unintentional), sequela
T452X2APoisoning by vitamins, intentional self-harm, initial encounter
T452X2SPoisoning by vitamins, intentional self-harm, sequela
T452X3APoisoning by vitamins, assault, initial encounter
T452X3SPoisoning by vitamins, assault, sequela
T452X4APoisoning by vitamins, undetermined, initial encounter
T452X4SPoisoning by vitamins, undetermined, sequela
T452X5AAdverse effect of vitamins, initial encounter
T452X5SAdverse effect of vitamins, sequela
T453X1APoisoning by enzymes, accidental (unintentional), initial encounter
T453X1SPoisoning by enzymes, accidental (unintentional), sequela
T453X2APoisoning by enzymes, intentional self-harm, initial encounter
T453X2SPoisoning by enzymes, intentional self-harm, sequela
T453X3APoisoning by enzymes, assault, initial encounter
T453X3SPoisoning by enzymes, assault, sequela
T453X4APoisoning by enzymes, undetermined, initial encounter
T453X4SPoisoning by enzymes, undetermined, sequela
T453X5AAdverse effect of enzymes, initial encounter
T453X5SAdverse effect of enzymes, sequela
T454X1APoisoning by iron and its compounds, accidental (unintentional), initial encounter
T454X1SPoisoning by iron and its compounds, accidental (unintentional), sequela
T454X2APoisoning by iron and its compounds, intentional self-harm, initial encounter
T454X2SPoisoning by iron and its compounds, intentional self-harm, sequela
T454X3APoisoning by iron and its compounds, assault, initial encounter
T454X3SPoisoning by iron and its compounds, assault, sequela
T454X4APoisoning by iron and its compounds, undetermined, initial encounter
T454X4SPoisoning by iron and its compounds, undetermined, sequela
T454X5AAdverse effect of iron and its compounds, initial encounter
T454X5SAdverse effect of iron and its compounds, sequela
T45511APoisoning by anticoagulants, accidental (unintentional), initial encounter
T45511SPoisoning by anticoagulants, accidental (unintentional), sequela
T45512APoisoning by anticoagulants, intentional self-harm, initial encounter
T45512SPoisoning by anticoagulants, intentional self-harm, sequela
T45513APoisoning by anticoagulants, assault, initial encounter
T45513SPoisoning by anticoagulants, assault, sequela
T45514APoisoning by anticoagulants, undetermined, initial encounter
T45514SPoisoning by anticoagulants, undetermined, sequela
T45515AAdverse effect of anticoagulants, initial encounter
T45515SAdverse effect of anticoagulants, sequela
T45521APoisoning by antithrombotic drugs, accidental (unintentional), initial encounter
T45521SPoisoning by antithrombotic drugs, accidental (unintentional), sequela
T45522APoisoning by antithrombotic drugs, intentional self-harm, initial encounter
T45522SPoisoning by antithrombotic drugs, intentional self-harm, sequela
T45523APoisoning by antithrombotic drugs, assault, initial encounter
T45523SPoisoning by antithrombotic drugs, assault, sequela
T45524APoisoning by antithrombotic drugs, undetermined, initial encounter
T45524SPoisoning by antithrombotic drugs, undetermined, sequela
T45525AAdverse effect of antithrombotic drugs, initial encounter
T45525SAdverse effect of antithrombotic drugs, sequela
T45601APoisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), initial encounter
T45601SPoisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), sequela
T45602APoisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, initial encounter
T45602SPoisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, sequela
T45603APoisoning by unspecified fibrinolysis-affecting drugs, assault, initial encounter
T45603SPoisoning by unspecified fibrinolysis-affecting drugs, assault, sequela
T45604APoisoning by unspecified fibrinolysis-affecting drugs, undetermined, initial encounter
T45604SPoisoning by unspecified fibrinolysis-affecting drugs, undetermined, sequela
T45605AAdverse effect of unspecified fibrinolysis-affecting drugs, initial encounter
T45605SAdverse effect of unspecified fibrinolysis-affecting drugs, sequela
T45611APoisoning by thrombolytic drug, accidental (unintentional), initial encounter
T45611SPoisoning by thrombolytic drug, accidental (unintentional), sequela
T45612APoisoning by thrombolytic drug, intentional self-harm, initial encounter
T45612SPoisoning by thrombolytic drug, intentional self-harm, sequela
T45613APoisoning by thrombolytic drug, assault, initial encounter
T45613SPoisoning by thrombolytic drug, assault, sequela
T45614APoisoning by thrombolytic drug, undetermined, initial encounter
T45614SPoisoning by thrombolytic drug, undetermined, sequela
T45615AAdverse effect of thrombolytic drugs, initial encounter
T45615SAdverse effect of thrombolytic drugs, sequela
T45621APoisoning by hemostatic drug, accidental (unintentional), initial encounter
T45621SPoisoning by hemostatic drug, accidental (unintentional), sequela
T45622APoisoning by hemostatic drug, intentional self-harm, initial encounter
T45622SPoisoning by hemostatic drug, intentional self-harm, sequela
T45623APoisoning by hemostatic drug, assault, initial encounter
T45623SPoisoning by hemostatic drug, assault, sequela
T45624APoisoning by hemostatic drug, undetermined, initial encounter
T45624SPoisoning by hemostatic drug, undetermined, sequela
T45625AAdverse effect of hemostatic drug, initial encounter
T45625SAdverse effect of hemostatic drug, sequela
T45691APoisoning by other fibrinolysis-affecting drugs, accidental (unintentional), initial encounter
T45691SPoisoning by other fibrinolysis-affecting drugs, accidental (unintentional), sequela
T45692APoisoning by other fibrinolysis-affecting drugs, intentional self-harm, initial encounter
T45692SPoisoning by other fibrinolysis-affecting drugs, intentional self-harm, sequela
T45693APoisoning by other fibrinolysis-affecting drugs, assault, initial encounter
T45693SPoisoning by other fibrinolysis-affecting drugs, assault, sequela
T45694APoisoning by other fibrinolysis-affecting drugs, undetermined, initial encounter
T45694SPoisoning by other fibrinolysis-affecting drugs, undetermined, sequela
T45695AAdverse effect of other fibrinolysis-affecting drugs, initial encounter
T45695SAdverse effect of other fibrinolysis-affecting drugs, sequela
T457X1APoisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), initial encounter
T457X1SPoisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), sequela
T457X2APoisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, initial encounter
T457X2SPoisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, sequela
T457X3APoisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, initial encounter
T457X3SPoisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, sequela
T457X4APoisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, initial encounter
T457X4SPoisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, sequela
T457X5AAdverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter
T457X5SAdverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela
T458X1APoisoning by other primarily systemic and hematological agents, accidental (unintentional), initial encounter
T458X1SPoisoning by other primarily systemic and hematological agents, accidental (unintentional), sequela
T458X2APoisoning by other primarily systemic and hematological agents, intentional self-harm, initial encounter
T458X2SPoisoning by other primarily systemic and hematological agents, intentional self-harm, sequela
T458X3APoisoning by other primarily systemic and hematological agents, assault, initial encounter
T458X3SPoisoning by other primarily systemic and hematological agents, assault, sequela
T458X4APoisoning by other primarily systemic and hematological agents, undetermined, initial encounter
T458X4SPoisoning by other primarily systemic and hematological agents, undetermined, sequela
T458X5AAdverse effect of other primarily systemic and hematological agents, initial encounter
T458X5SAdverse effect of other primarily systemic and hematological agents, sequela
T4591XAPoisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), initial encounter
T4591XSPoisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), sequela
T4592XAPoisoning by unspecified primarily systemic and hematological agent, intentional self-harm, initial encounter
T4592XSPoisoning by unspecified primarily systemic and hematological agent, intentional self-harm, sequela
T4593XAPoisoning by unspecified primarily systemic and hematological agent, assault, initial encounter
T4593XSPoisoning by unspecified primarily systemic and hematological agent, assault, sequela
T4594XAPoisoning by unspecified primarily systemic and hematological agent, undetermined, initial encounter
T4594XSPoisoning by unspecified primarily systemic and hematological agent, undetermined, sequela
T4595XAAdverse effect of unspecified primarily systemic and hematological agent, initial encounter
T4595XSAdverse effect of unspecified primarily systemic and hematological agent, sequela
T460X1APoisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter
T460X1SPoisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), sequela
T460X2APoisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter
T460X2SPoisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela
T460X3APoisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter
T460X3SPoisoning by cardiac-stimulant glycosides and drugs of similar action, assault, sequela
T460X4APoisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter
T460X4SPoisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, sequela
T460X5AAdverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
T460X5SAdverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
T461X1APoisoning by calcium-channel blockers, accidental (unintentional), initial encounter
T461X1SPoisoning by calcium-channel blockers, accidental (unintentional), sequela
T461X2APoisoning by calcium-channel blockers, intentional self-harm, initial encounter
T461X2SPoisoning by calcium-channel blockers, intentional self-harm, sequela
T461X3APoisoning by calcium-channel blockers, assault, initial encounter
T461X3SPoisoning by calcium-channel blockers, assault, sequela
T461X4APoisoning by calcium-channel blockers, undetermined, initial encounter
T461X4SPoisoning by calcium-channel blockers, undetermined, sequela
T461X5AAdverse effect of calcium-channel blockers, initial encounter
T461X5SAdverse effect of calcium-channel blockers, sequela
T462X1APoisoning by other antidysrhythmic drugs, accidental (unintentional), initial encounter
T462X1SPoisoning by other antidysrhythmic drugs, accidental (unintentional), sequela
T462X2APoisoning by other antidysrhythmic drugs, intentional self-harm, initial encounter
T462X2SPoisoning by other antidysrhythmic drugs, intentional self-harm, sequela
T462X3APoisoning by other antidysrhythmic drugs, assault, initial encounter
T462X3SPoisoning by other antidysrhythmic drugs, assault, sequela
T462X4APoisoning by other antidysrhythmic drugs, undetermined, initial encounter
T462X4SPoisoning by other antidysrhythmic drugs, undetermined, sequela
T462X5AAdverse effect of other antidysrhythmic drugs, initial encounter
T462X5SAdverse effect of other antidysrhythmic drugs, sequela
T463X1APoisoning by coronary vasodilators, accidental (unintentional), initial encounter
T463X1SPoisoning by coronary vasodilators, accidental (unintentional), sequela
T463X2APoisoning by coronary vasodilators, intentional self-harm, initial encounter
T463X2SPoisoning by coronary vasodilators, intentional self-harm, sequela
T463X3APoisoning by coronary vasodilators, assault, initial encounter
T463X3SPoisoning by coronary vasodilators, assault, sequela
T463X4APoisoning by coronary vasodilators, undetermined, initial encounter
T463X4SPoisoning by coronary vasodilators, undetermined, sequela
T463X5AAdverse effect of coronary vasodilators, initial encounter
T463X5SAdverse effect of coronary vasodilators, sequela
T464X1APoisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter
T464X1SPoisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), sequela
T464X2APoisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter
T464X2SPoisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequela
T464X3APoisoning by angiotensin-converting-enzyme inhibitors, assault, initial encounter
T464X3SPoisoning by angiotensin-converting-enzyme inhibitors, assault, sequela
T464X4APoisoning by angiotensin-converting-enzyme inhibitors, undetermined, initial encounter
T464X4SPoisoning by angiotensin-converting-enzyme inhibitors, undetermined, sequela
T464X5AAdverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
T464X5SAdverse effect of angiotensin-converting-enzyme inhibitors, sequela
T465X1APoisoning by other antihypertensive drugs, accidental (unintentional), initial encounter
T465X1SPoisoning by other antihypertensive drugs, accidental (unintentional), sequela
T465X2APoisoning by other antihypertensive drugs, intentional self-harm, initial encounter
T465X2SPoisoning by other antihypertensive drugs, intentional self-harm, sequela
T465X3APoisoning by other antihypertensive drugs, assault, initial encounter
T465X3SPoisoning by other antihypertensive drugs, assault, sequela
T465X4APoisoning by other antihypertensive drugs, undetermined, initial encounter
T465X4SPoisoning by other antihypertensive drugs, undetermined, sequela
T465X5AAdverse effect of other antihypertensive drugs, initial encounter
T465X5SAdverse effect of other antihypertensive drugs, sequela
T466X1APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), initial encounter
T466X1SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela
T466X2APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, initial encounter
T466X2SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, sequela
T466X3APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, initial encounter
T466X3SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, sequela
T466X4APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, initial encounter
T466X4SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, sequela
T466X5AAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
T466X5SAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela
T467X1APoisoning by peripheral vasodilators, accidental (unintentional), initial encounter
T467X1SPoisoning by peripheral vasodilators, accidental (unintentional), sequela
T467X2APoisoning by peripheral vasodilators, intentional self-harm, initial encounter
T467X2SPoisoning by peripheral vasodilators, intentional self-harm, sequela
T467X3APoisoning by peripheral vasodilators, assault, initial encounter
T467X3SPoisoning by peripheral vasodilators, assault, sequela
T467X4APoisoning by peripheral vasodilators, undetermined, initial encounter
T467X4SPoisoning by peripheral vasodilators, undetermined, sequela
T467X5AAdverse effect of peripheral vasodilators, initial encounter
T467X5SAdverse effect of peripheral vasodilators, sequela
T468X1APoisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter
T468X1SPoisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequela
T468X2APoisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter
T468X2SPoisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela
T468X3APoisoning by antivaricose drugs, including sclerosing agents, assault, initial encounter
T468X3SPoisoning by antivaricose drugs, including sclerosing agents, assault, sequela
T468X4APoisoning by antivaricose drugs, including sclerosing agents, undetermined, initial encounter
T468X4SPoisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela
T468X5AAdverse effect of antivaricose drugs, including sclerosing agents, initial encounter
T468X5SAdverse effect of antivaricose drugs, including sclerosing agents, sequela
T46901APoisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
T46901SPoisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
T46902APoisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
T46902SPoisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequela
T46903APoisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial encounter
T46903SPoisoning by unspecified agents primarily affecting the cardiovascular system, assault, sequela
T46904APoisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, initial encounter
T46904SPoisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, sequela
T46905AAdverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
T46905SAdverse effect of unspecified agents primarily affecting the cardiovascular system, sequela
T46991APoisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
T46991SPoisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
T46992APoisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
T46992SPoisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, sequela
T46993APoisoning by other agents primarily affecting the cardiovascular system, assault, initial encounter
T46993SPoisoning by other agents primarily affecting the cardiovascular system, assault, sequela
T46994APoisoning by other agents primarily affecting the cardiovascular system, undetermined, initial encounter
T46994SPoisoning by other agents primarily affecting the cardiovascular system, undetermined, sequela
T46995AAdverse effect of other agents primarily affecting the cardiovascular system, initial encounter
T46995SAdverse effect of other agents primarily affecting the cardiovascular system, sequela
T470X1APoisoning by histamine H2-receptor blockers, accidental (unintentional), initial encounter
T470X1SPoisoning by histamine H2-receptor blockers, accidental (unintentional), sequela
T470X2APoisoning by histamine H2-receptor blockers, intentional self-harm, initial encounter
T470X2SPoisoning by histamine H2-receptor blockers, intentional self-harm, sequela
T470X3APoisoning by histamine H2-receptor blockers, assault, initial encounter
T470X3SPoisoning by histamine H2-receptor blockers, assault, sequela
T470X4APoisoning by histamine H2-receptor blockers, undetermined, initial encounter
T470X4SPoisoning by histamine H2-receptor blockers, undetermined, sequela
T470X5AAdverse effect of histamine H2-receptor blockers, initial encounter
T470X5SAdverse effect of histamine H2-receptor blockers, sequela
T471X1APoisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), initial encounter
T471X1SPoisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), sequela
T471X2APoisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, initial encounter
T471X2SPoisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, sequela
T471X3APoisoning by other antacids and anti-gastric-secretion drugs, assault, initial encounter
T471X3SPoisoning by other antacids and anti-gastric-secretion drugs, assault, sequela
T471X4APoisoning by other antacids and anti-gastric-secretion drugs, undetermined, initial encounter
T471X4SPoisoning by other antacids and anti-gastric-secretion drugs, undetermined, sequela
T471X5AAdverse effect of other antacids and anti-gastric-secretion drugs, initial encounter
T471X5SAdverse effect of other antacids and anti-gastric-secretion drugs, sequela
T472X1APoisoning by stimulant laxatives, accidental (unintentional), initial encounter
T472X1SPoisoning by stimulant laxatives, accidental (unintentional), sequela
T472X2APoisoning by stimulant laxatives, intentional self-harm, initial encounter
T472X2SPoisoning by stimulant laxatives, intentional self-harm, sequela
T472X3APoisoning by stimulant laxatives, assault, initial encounter
T472X3SPoisoning by stimulant laxatives, assault, sequela
T472X4APoisoning by stimulant laxatives, undetermined, initial encounter
T472X4SPoisoning by stimulant laxatives, undetermined, sequela
T472X5AAdverse effect of stimulant laxatives, initial encounter
T472X5SAdverse effect of stimulant laxatives, sequela
T473X1APoisoning by saline and osmotic laxatives, accidental (unintentional), initial encounter
T473X1SPoisoning by saline and osmotic laxatives, accidental (unintentional), sequela
T473X2APoisoning by saline and osmotic laxatives, intentional self-harm, initial encounter
T473X2SPoisoning by saline and osmotic laxatives, intentional self-harm, sequela
T473X3APoisoning by saline and osmotic laxatives, assault, initial encounter
T473X3SPoisoning by saline and osmotic laxatives, assault, sequela
T473X4APoisoning by saline and osmotic laxatives, undetermined, initial encounter
T473X4SPoisoning by saline and osmotic laxatives, undetermined, sequela
T473X5AAdverse effect of saline and osmotic laxatives, initial encounter
T473X5SAdverse effect of saline and osmotic laxatives, sequela
T474X1APoisoning by other laxatives, accidental (unintentional), initial encounter
T474X1SPoisoning by other laxatives, accidental (unintentional), sequela
T474X2APoisoning by other laxatives, intentional self-harm, initial encounter
T474X2SPoisoning by other laxatives, intentional self-harm, sequela
T474X3APoisoning by other laxatives, assault, initial encounter
T474X3SPoisoning by other laxatives, assault, sequela
T474X4APoisoning by other laxatives, undetermined, initial encounter
T474X4SPoisoning by other laxatives, undetermined, sequela
T474X5AAdverse effect of other laxatives, initial encounter
T474X5SAdverse effect of other laxatives, sequela
T475X1APoisoning by digestants, accidental (unintentional), initial encounter
T475X1SPoisoning by digestants, accidental (unintentional), sequela
T475X2APoisoning by digestants, intentional self-harm, initial encounter
T475X2SPoisoning by digestants, intentional self-harm, sequela
T475X3APoisoning by digestants, assault, initial encounter
T475X3SPoisoning by digestants, assault, sequela
T475X4APoisoning by digestants, undetermined, initial encounter
T475X4SPoisoning by digestants, undetermined, sequela
T475X5AAdverse effect of digestants, initial encounter
T475X5SAdverse effect of digestants, sequela
T476X1APoisoning by antidiarrheal drugs, accidental (unintentional), initial encounter
T476X1SPoisoning by antidiarrheal drugs, accidental (unintentional), sequela
T476X2APoisoning by antidiarrheal drugs, intentional self-harm, initial encounter
T476X2SPoisoning by antidiarrheal drugs, intentional self-harm, sequela
T476X3APoisoning by antidiarrheal drugs, assault, initial encounter
T476X3SPoisoning by antidiarrheal drugs, assault, sequela
T476X4APoisoning by antidiarrheal drugs, undetermined, initial encounter
T476X4SPoisoning by antidiarrheal drugs, undetermined, sequela
T476X5AAdverse effect of antidiarrheal drugs, initial encounter
T476X5SAdverse effect of antidiarrheal drugs, sequela
T477X1APoisoning by emetics, accidental (unintentional), initial encounter
T477X1SPoisoning by emetics, accidental (unintentional), sequela
T477X2APoisoning by emetics, intentional self-harm, initial encounter
T477X2SPoisoning by emetics, intentional self-harm, sequela
T477X3APoisoning by emetics, assault, initial encounter
T477X3SPoisoning by emetics, assault, sequela
T477X4APoisoning by emetics, undetermined, initial encounter
T477X4SPoisoning by emetics, undetermined, sequela
T477X5AAdverse effect of emetics, initial encounter
T477X5SAdverse effect of emetics, sequela
T478X1APoisoning by other agents primarily affecting gastrointestinal system, accidental (unintentional), initial encounter
T478X1SPoisoning by other agents primarily affecting gastrointestinal system, accidental (unintentional), sequela
T478X2APoisoning by other agents primarily affecting gastrointestinal system, intentional self-harm, initial encounter
T478X2SPoisoning by other agents primarily affecting gastrointestinal system, intentional self-harm, sequela
T478X3APoisoning by other agents primarily affecting gastrointestinal system, assault, initial encounter
T478X3SPoisoning by other agents primarily affecting gastrointestinal system, assault, sequela
T478X4APoisoning by other agents primarily affecting gastrointestinal system, undetermined, initial encounter
T478X4SPoisoning by other agents primarily affecting gastrointestinal system, undetermined, sequela
T478X5AAdverse effect of other agents primarily affecting gastrointestinal system, initial encounter
T478X5SAdverse effect of other agents primarily affecting gastrointestinal system, sequela
T4791XAPoisoning by unspecified agents primarily affecting the gastrointestinal system, accidental (unintentional), initial encounter
T4791XSPoisoning by unspecified agents primarily affecting the gastrointestinal system, accidental (unintentional), sequela
T4792XAPoisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm, initial encounter
T4792XSPoisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm, sequela
T4793XAPoisoning by unspecified agents primarily affecting the gastrointestinal system, assault, initial encounter
T4793XSPoisoning by unspecified agents primarily affecting the gastrointestinal system, assault, sequela
T4794XAPoisoning by unspecified agents primarily affecting the gastrointestinal system, undetermined, initial encounter
T4794XSPoisoning by unspecified agents primarily affecting the gastrointestinal system, undetermined, sequela
T4795XAAdverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter
T4795XSAdverse effect of unspecified agents primarily affecting the gastrointestinal system, sequela
T480X1APoisoning by oxytocic drugs, accidental (unintentional), initial encounter
T480X1SPoisoning by oxytocic drugs, accidental (unintentional), sequela
T480X2APoisoning by oxytocic drugs, intentional self-harm, initial encounter
T480X2SPoisoning by oxytocic drugs, intentional self-harm, sequela
T480X3APoisoning by oxytocic drugs, assault, initial encounter
T480X3SPoisoning by oxytocic drugs, assault, sequela
T480X4APoisoning by oxytocic drugs, undetermined, initial encounter
T480X4SPoisoning by oxytocic drugs, undetermined, sequela
T480X5AAdverse effect of oxytocic drugs, initial encounter
T480X5SAdverse effect of oxytocic drugs, sequela
T481X1APoisoning by skeletal muscle relaxants [neuromuscular blocking agents], accidental (unintentional), initial encounter
T481X1SPoisoning by skeletal muscle relaxants [neuromuscular blocking agents], accidental (unintentional), sequela
T481X2APoisoning by skeletal muscle relaxants [neuromuscular blocking agents], intentional self-harm, initial encounter
T481X2SPoisoning by skeletal muscle relaxants [neuromuscular blocking agents], intentional self-harm, sequela
T481X3APoisoning by skeletal muscle relaxants [neuromuscular blocking agents], assault, initial encounter
T481X3SPoisoning by skeletal muscle relaxants [neuromuscular blocking agents], assault, sequela
T481X4APoisoning by skeletal muscle relaxants [neuromuscular blocking agents], undetermined, initial encounter
T481X4SPoisoning by skeletal muscle relaxants [neuromuscular blocking agents], undetermined, sequela
T481X5AAdverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
T481X5SAdverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequela
T48201APoisoning by unspecified drugs acting on muscles, accidental (unintentional), initial encounter
T48201SPoisoning by unspecified drugs acting on muscles, accidental (unintentional), sequela
T48202APoisoning by unspecified drugs acting on muscles, intentional self-harm, initial encounter
T48202SPoisoning by unspecified drugs acting on muscles, intentional self-harm, sequela
T48203APoisoning by unspecified drugs acting on muscles, assault, initial encounter
T48203SPoisoning by unspecified drugs acting on muscles, assault, sequela
T48204APoisoning by unspecified drugs acting on muscles, undetermined, initial encounter
T48204SPoisoning by unspecified drugs acting on muscles, undetermined, sequela
T48205AAdverse effect of unspecified drugs acting on muscles, initial encounter
T48205SAdverse effect of unspecified drugs acting on muscles, sequela
T48291APoisoning by other drugs acting on muscles, accidental (unintentional), initial encounter
T48291SPoisoning by other drugs acting on muscles, accidental (unintentional), sequela
T48292APoisoning by other drugs acting on muscles, intentional self-harm, initial encounter
T48292SPoisoning by other drugs acting on muscles, intentional self-harm, sequela
T48293APoisoning by other drugs acting on muscles, assault, initial encounter
T48293SPoisoning by other drugs acting on muscles, assault, sequela



Centers for Medicare & Medicaid Services, 7500 Security Boulevard Baltimore, MD 21244